Protocols
1 protocol(s) meet the specified criteria
Drug: mFOLFOX-6
Protocol No.TitleStatus
NRG-GI004-CIRBColorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study: A Randomized Phase III Study of mFOLFOX6/Bevacizumab Combination Chemotherapy with or without Atezolizumab or Atezolizumab Monotherapy in the First-Line Treatment of Patients with Deficient DNA Mismatch Repair (dMMR) Metastatic Colorectal CancerOpen